← All companies

PRFX

PRF Technologies Ltd.

PRFX Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.00

-0.03 -2.91%

Key statistics

from XBRL data in SEC filings

Market cap

$831K

Revenue (TTM)

$17.0K

Net income (TTM)

-$5.02M

EPS (TTM)

$-7.47

P/E ratio

—

Dividend yield

—

Free cash flow

-$3.96M

Cash

$3.13M

Total assets

$12.0M

Gross margin

—

52-week range

$0.97 – $17.95

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 27, 2026 6-K Jul 21, 2026 6-K Jul 15, 2026 6-K Jul 8, 2026 6-K Jun 25, 2026 6-K Jun 18, 2026 6-K May 28, 2026 6-K May 26, 2026 6-K May 7, 2026 6-K Apr 28, 2026 6-K Mar 27, 2026 20-F Mar 26, 2026 6-K Mar 17, 2026 6-K Mar 3, 2026 6-K Feb 18, 2026 6-K Feb 11, 2026 6-K Feb 3, 2026 6-K Jan 20, 2026 6-K Jan 15, 2026 6-K Jan 12, 2026 6-K Jan 7, 2026 6-K Jan 6, 2026 6-K Jan 5, 2026 6-K Dec 30, 2025 6-K Dec 10, 2025 6-K Dec 2, 2025 6-K Nov 25, 2025 6-K Nov 12, 2025 6-K Nov 5, 2025 6-K Oct 1, 2025 6-K Aug 19, 2025 6-K Aug 13, 2025 6-K Jul 10, 2025 6-K May 7, 2025 6-K Apr 17, 2025 6-K Apr 11, 2025 6-K Apr 10, 2025 6-K Apr 7, 2025 20-F Apr 7, 2025 6-K Apr 3, 2025